A Multicenter Phase II/III-study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer (Affibody-3).
Condition: HER2-positive Breast Cancer Intervention: Diagnostic Test: ABY-PET Sponsors: Henrik Lindman; Roche Pharma AG; Swedish Cancer Society; Affibody; Swedish Breast Cancer Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials